Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Switzerland

BfArM Approves Generic Plavix

May 2008 | Industry News

Germany's main regulatory body, the Federal Institute for Drugs and Medical Devices (BfArM), has controversially approved a generic form of global blockbuster Plavix (clopidogrel). The generic form of clopidogrel was developed by a small Swiss company, Cimex, a member of the Schweizerhall group. As a result, Sanofi-Aventis immediately launched a legal action, claiming the drug registration was obtained illegally.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Sandoz H108 Results Highlight Successful Growth In CEE

Industry / Switzerland Strong growth in Central and Eastern Europe (CEE) for Sandoz, Novartis' generics division, has made a significant contribution to the generics company's H108 results. In US dollar terms, sales grew by...
July 2008
Nycomed Divests Cancer Research Projects

Industry / Switzerland Switzerland-based drugmaker Nycomed is planning to sell part of its oncology pipeline to German firm 4SC in order to focus on developing drugs in its current areas of speciality. Eight projects in pre-clinical...
June 2008
Novartis And Bayer To Go Head To Head Following EU Extavia Approval

Industry / Switzerland Swiss drugmaker Novartis has obtained EU approval for its multiple sclerosis (MS) treatment Extavia (interferon beta-1b), which will result in a head-to-head battle with Bayer's identical competitor...
May 2008
Roche Looks Forward To 2007 As Biotech Boom Continues

Companies / Switzerland Switzerland's major drugmakers Roche and Novartis have both experienced strong growth over the past five years and are generally acknowledged to be among the most successful of the pharmaceutical...
January 2007
Merck KGaA Bids For Serono

Companies / Switzerland In a shock move, German firm Merck KGaA has unveiled a US$13.3bn bid for Swiss biotechnology company Serono, to create a new heavyweight player in the European pharmaceuticals sector.
September 2006
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS